Seung-Pyo Hong

Corporate Officer/Principal at INFOBANK CORPORATION

52 year

Technology Services

Consumer Services

Health Technology

Profile

Seung-Pyo Hong is currently the Managing Director & Head-iMessage Business at InfoBank Corp.
and the Director at BioActs Co., Ltd.
He completed his undergraduate degree at Kyung Hee University.

Seung-Pyo Hong active positions

Companies	Position	Start
INFOBANK CORPORATION	Corporate Officer/Principal	-
BioActs Co., Ltd. BioActs Co., Ltd. Medical SpecialtiesHealth Technology BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.	Director/Board Member	-

All active positions of Seung-Pyo Hong

Training of Seung-Pyo Hong

Kyung Hee University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Seung-Pyo Hong's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INFOBANK CORPORATION	Technology Services

Private companies	1
BioActs Co., Ltd. BioActs Co., Ltd. Medical SpecialtiesHealth Technology BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.	Health Technology